Subscribe

Immune-Related Adverse Events (irAE) Associated with the anti-CTLA-4 Antibodies Ipilimumab and Tremelimumab

Specialty:

Hematology Oncology
Immunology/Rheumatology

Objective:

ICD-10:

Description:

Targeted monoclonal antibodies to CTLA-4 (T-lymphocyte antigen-4, CD152) have shown promise in the treatment of malignant melanoma and other tumors, but may be complicated by autoimmune diseases.

To read more or access our algorithms and calculators, please log in or register.

RECENT TWEETS

medal descover
medal iphone